


Searching News Database: smoking cessation
HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
HSMN NewsFeed - 6 Jan 2017
OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
HSMN NewsFeed - 7 Nov 2011
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
HSMN NewsFeed - 25 Dec 2009
Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
HSMN NewsFeed - 16 Nov 2009
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
HSMN NewsFeed - 7 Apr 2009
IntelGenx Corp. and Cary Pharmaceuticals File NDA for CPI-300 Antidepressant
IntelGenx Corp. and Cary Pharmaceuticals File NDA for CPI-300 Antidepressant
HSMN NewsFeed - 22 Apr 2008
Pfizer Japan to Launch Champix(R) the First Prescription Oral Smoking Cessation Aid in Japan
Pfizer Japan to Launch Champix(R) the First Prescription Oral Smoking Cessation Aid in Japan
HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
HSMN NewsFeed - 28 Jan 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)
HSMN NewsFeed - 22 Jan 2008
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
HSMN NewsFeed - 18 Jan 2008
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
HSMN NewsFeed - 6 Dec 2007
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
HSMN NewsFeed - 30 Oct 2007
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
HSMN NewsFeed - 11 Sep 2007
Crospon Licenses HP Technology to Create Industry-First Skin Patch for ''Smart'' Drug Delivery
Crospon Licenses HP Technology to Create Industry-First Skin Patch for ''Smart'' Drug Delivery
HSMN NewsFeed - 23 Jul 2007
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
HSMN NewsFeed - 22 Jun 2007
FDA Approves Novartis Consumer Health, Inc.'s Over-the-Counter THRIVE(TM) Gum for Cessation of Smoking
FDA Approves Novartis Consumer Health, Inc.'s Over-the-Counter THRIVE(TM) Gum for Cessation of Smoking
HSMN NewsFeed - 21 Jun 2007
Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review
Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review
HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
HSMN NewsFeed - 20 May 2007
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
HSMN NewsFeed - 9 May 2007
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
HSMN NewsFeed - 2 May 2007
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 13 Feb 2007
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
HSMN NewsFeed - 29 Jan 2007
Somaxon Pharmaceuticals Names Robert Jones Vice President, Human Resources
Somaxon Pharmaceuticals Names Robert Jones Vice President, Human Resources
HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
HSMN NewsFeed - 8 Jan 2007
VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener
VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener
HSMN NewsFeed - 13 Nov 2006
Somaxon Pharmaceuticals Names Brian Dorsey Vice President of Manufacturing and Program Management
Somaxon Pharmaceuticals Names Brian Dorsey Vice President of Manufacturing and Program Management
HSMN NewsFeed - 13 Sep 2006
Heart Failure Patient Quality of Care Improves at Hospitals in the Get With The Guidelines(SM) Program
Heart Failure Patient Quality of Care Improves at Hospitals in the Get With The Guidelines(SM) Program
HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
HSMN NewsFeed - 4 Jul 2006
Data Show CHANTIX(TM) (varenicline) Provides Smokers New Hope to Quit Smoking
Data Show CHANTIX(TM) (varenicline) Provides Smokers New Hope to Quit Smoking
HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
HSMN NewsFeed - 11 May 2006
Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval
Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval
HSMN NewsFeed - 9 May 2006
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Additional items found! 43
Members Archive contains
43 additional stories matching:
smoking cessation
(Password required)
smoking cessation
(Password required)
